Ingested soluble CD14 contributes to the functional pool of circulating sCD14 in mice  by Ward, Tonya L. et al.
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a  b  s  t  r  a  c  t
Soluble  CD14  (sCD14)  is a  pattern  recognition  receptor  and  Toll-like  co-receptor  observed  in  human  milk
(5–26 g/mL)  and other  bodily  ﬂuids  such  as  blood  (3 g/mL).  The  most  well  deﬁned  role  of sCD14  is to
recognize  lipopolysaccharide  of  Gram-negative  bacteria  and  signal  an  immune  response  through  Toll-
like receptor  4  (TLR4).  Previous  research  has shown  ingested  sCD14  to  transfer  from  the  gastrointestinal
tract  and  into  the blood  stream  in  neonatal  rats. The contribution  of  human  milk  sCD14  to  circulating
levels  in  the  infant  and  the functionality  of the  protein,  however,  remained  unknown.  Using  CD14−/−
mouse  pups  fostered  to wild  type  (WT)  mothers  expressing  sCD14  in  their  milk,  we show  herein that
ingestion  of  sCD14  resulted  in  blood  sCD14  levels  up 0.16  ± 0.09 g/mL.  This  represents  almost  one-
third  (26.7%)  of  the  circulating  sCD14  observed  in WT  pups  fostered  to WT  mothers  (0.60  ± 0.14  g/mL).
We  also  demonstrate  that ingested-sCD14  transferred  to the  blood  remains  functional  in its ability
to  recognize  lipopolysaccharide  as demonstrated  by a signiﬁcant  increase  in immune  response  (IL-6
and TNF-)  in CD14−/− pups  fostered  to  WT  mothers  in  comparison  to  control  animals  (P  =  0.002  and
P  =  0.007,  respectively).  Using  human  intestinal  cells  (Caco-2),  we  also  observed  a signiﬁcant  decrease  in
sCD14  transcytosis  when  TLR4 was  knocked  down  (P  < 0.001),  suggesting  sCD14 transfer  involves  TLR4.
The  bioavailability  of human  milk  sCD14  established  in this  report  conﬁrms  the  importance  of  human
milk  proteins  for  the infant  and demonstrates  the  need  to improve  infant  formulas  which are  lacking  in
immune  proteins  such  as  sCD14.
© 2014  The  Authors.  Published  by  Elsevier  GmbH.  This  is an  open  access  article  under  the CCntroduction
Human milk consumption in comparison to infant formula
as been linked to beneﬁcial health outcomes for the infant
uch as decreased incidence of necrotizing enterocolitis (NEC)
Maayan-Metzger et al., 2004; Sullivan et al., 2010). The bioac-
ive components of human milk linked to health beneﬁts for
nfants include prebiotics, probiotics and innate immune compo-
ents. One such immune component is cluster of differentiation
4 (CD14). CD14 is a pattern recognition receptor found in two
orms, membrane bound CD14 (mCD14) on the surface of cells,
r as a soluble protein (sCD14) in bodily ﬂuids such as tears
0.5 g/mL), blood (3 g/mL) and milk (5–26 g/mL, depending
Abbreviations: CD14, cluster of differentiation 14; GI, gastrointestinal; hrCD14,
uman recombinant CD14; HTLV-1, human T-cell lymphotrophic virus type 1;
CD14, membrane bound CD14; NEC, necrotizing enterocolitis; PP, post-partum;
CD14, soluble CD14; TLR4, Toll-like receptor 4; WT,  wild type.
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on time of lactation) (Blais et al., 2005; Collado et al., 2012). Both
forms of CD14 are responsible for the detection of several bacterial
components including lipopolysaccharide (LPS) of Gram-negative
bacteria (Wright et al., 1990). In combination with Toll-like recep-
tor 4 (TLR4), detection of LPS by CD14 results in a proinﬂammatory
immune response through both the TIRAP-MyD88 dependent
pathway and the TRAM-TRIF dependent pathway (Kagan and
Medzhitov, 2006; Kagan et al., 2008). sCD14, in comparison to
mCD14, can also decrease the immune response to LPS by seques-
tering LPS from mCD14-expressing cells and providing clearance of
LPS through the liver (Deng et al., 2013; Haziot et al., 2001).
To provide beneﬁt for the infant, bioactive milk components,
including sCD14, must remain intact and functional post-ingestion.
In our previous study, a signiﬁcant portion (3.4 ± 2.2%) of
radiolabeled-human recombinant sCD14 survived gastrointestinal
(GI) transit post-ingestion and was  transferred, intact, into the
blood of rat pups (Ward et al., 2014). The total amount of endoge-
nous milk CD14 transferred into the blood and its functionality,
however, remained unknown. We  hypothesized that sCD14 is a
major contributor to circulating sCD14 in infants, and that once
transferred to the blood, sCD14 remains functional.
access article under the CC BY-NC-SA license (http://creativecommons.org/
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Table 1
Fostering scheme used to determine the quantity and functionality of ingested
sCD14 transcytosed to the blood of mice.
Pup Foster
mother
Endpoint
WT WT - Total circulating sCD14
-  Positive control for LPS detection by sCD14
WT  CD14−/− - Contribution of pup-CD14 to circulating
sCD14
- Impact of lack of ingested sCD14 on LPS
detection
CD14−/− WT - Contribution of ingested sCD14 to
circulating sCD14
- Functionality of transferred sCD14 to detect
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CD14−/− CD14−/− - Negative control
Additionally, we sought to validate sCD14 transfer across the GI
ract using human intestinal epithelial cells, and to better elucidate
he mechanism by which sCD14 is transferred from the GI tract
nto the blood. In macrophages and dendritic cells, internalization
f TLR4 has been demonstrated through a CD14 interaction (Zanoni
t al., 2011). Although CD14 internalization has been shown to
e independent of TLR4 in immune cells (Zanoni et al., 2011),
e hypothesized that intestinal cells, which also express TLR4
Vamadevan et al., 2010), may  behave differently and that transfer
f sCD14 across the epithelium may  involve TLR4.
aterials and methods
nimals, fostering and LPS injection
Animal studies were conducted in accordance with the Uni-
ersity of Ottawa’s Animal Care and Veterinary Service under
pproval permit ID number ‘BMI-129’, and were approved by the
niversity of Ottawa’s Animal Care Committee. CD14 null mice
B6.129S-Cd14tm1Frm/J) and wild type controls of the same back-
round (C57BL/6J) were purchased from Jackson Laboratory (Bar
arbor, Maine, USA). Using an experimental design outlined in
able 1, mice were bred and pups were fostered at day 6 post-
artum (PP) to different mothers. Starting at day 0 (pre-foster) until
ay 4 post-foster, pups were removed from the litter, euthanized
y CO2 inhalation, and organs were harvested (see supplemental
ig. S1 for the fostering timeline). Separately, pups were fostered
s described above and injected intraperitoneally on day 2 post-
oster (day 8 PP) with LPS (200 ng/g body weight, Sigma–Aldrich,
akville, ON, Canada). Pups were monitored for signs of discomfort
nd at 2 h post-injection pups were euthanized by CO2 inhalation
nd organs were harvested (Ward et al., 2014).
Supplementary Fig. S1 related to this article can be found, in the
nline version, at http://dx.doi.org/10.1016/j.imbio.2014.03.008.
D14 and cytokine concentrations
To determine sCD14 concentrations in mouse milk, milk clots
rom the stomach of pups (15 mg)  were resuspended in 150 L
f protein extraction buffer (50 mM Tris–HCl pH 7.4, 2 mM
DTA, 150 mM NaCl, 0.5 mM DTT and protease inhibitor cock-
ail, Sigma–Aldrich). Stomach contents and blood samples were
nalyzed using mouse-speciﬁc ELISAs for CD14, TNF- and IL-
 (R&D Systems, Minneapolis, MN,  USA). Stomach contents and
lood samples were also analyzed by western blot to determine
D14 intactness. Samples, including 30 ng of mouse recombinant
D14 as a positive control (R&D Systems), were electrophoresed
sing SDS–PAGE and proteins were transferred to nitrocellulosegy 219 (2014) 537–546
membranes which were blocked with 5% BSA-TBST followed by
incubation with 0.5 g/mL rabbit anti-CD14 antibody (M-305,
Santa Cruz Biotechnology, Dallas, TX, USA) for one hour. Mem-
branes were washed three times and incubated with a 1:30,000
dilution of a chicken anti-rabbit IgG horse radish peroxidase (HRP)-
linked antibody (SC-2955, Santa Cruz Biotechnology). Following an
additional three washes proteins were visualized using exposure to
enhanced chemiluminescent (ECL) substrate (GE Healthcare, Pis-
cataway, NJ, USA).
Caco-2 cells and transport assays
Human intestine-derived Caco-2 and HT29 cells were grown in
Eagle’s minimum essential media (Life Technologies, Burlington,
ON, Canada) with a ﬁnal concentration of 2 mM l-glutamine, 1 mM
sodium pyruvate, sodium bicarbonate, 1× Antibiotic-Antimycotic
(Life Technologies) and 20% FBS (Life Technologies) at 37 ◦C and 5%
CO2. Biocoat HTS Caco-2 transport assays were completed as per the
manufacturer’s protocol (BD Biosciences, Franklin Lakes, NJ, USA).
Brieﬂy, cells were seeded on transport membranes and differen-
tiated for three days. Human recombinant soluble CD14 (hrCD14,
R&D Systems) was  added to the apical well. Media from both the
apical and basal well was collected 2 h post-addition for analysis
by human CD14-speciﬁc ELISA (R&D Systems). Passive transport
of Lucifer Yellow (444.25 mol  mass) was  used to determine mono-
layer intactness as per the manufacturer’s protocol. Lucifer Yellow
(70 M,  Sigma–Aldrich) was  added in addition to the soluble CD14
and was  detected in the media using a Typhoon Trio Imager (GE
Healthcare). Intactness of hrCD14 was  determined by western blot,
as described above with the exception of using an anti-human
CD14 primary antibody (1:1000 dilution, R&D Systems) and a rabbit
anti-mouse IgG HRP-linked secondary antibody (1:10,000 dilution,
HAF007, R&D Systems).
TLR4 siRNA knockdown
Caco-2 cells and HT29 cells were grown as described above.
RNA was isolated from cells using an RNeasy mini kit (Qiagen,
Valencia, CA, USA) and subsequently used to create cDNA using a
Maxima cDNA kit (Thermo Scientiﬁc, Waltham, MA, USA). TLR4 and
GAPDH cDNA were ampliﬁed using real-time PCR conditions (ABI
7500 Real Time PCR, Applied Biosystems, Burlington, ON, Canada)
as previously described and using the following primers TLR4:
5′-CTGCGTGAGACCAGAAAGC-3′, 5′-TTCAGCTCCATGCATTGATAA-
3′ (75 bp amplicon); GAPDH: 5′-AGCCACATCGCTCAGACAC-3′,
5′-GCCCAATACGACCAAATCC-3′ (66 bp amplicon) (Sanchez-Munoz
et al., 2011). Additionally, Caco-2 cells were seeded and differen-
tiated on a Biocoat HTS transport assay as described above (BD
Biosciences) and transfected with siRNA for TLR4 (SC-40,260) or
scrambled siRNA as a control as per the manufacturer’s instruc-
tions (Santa Cruz Biotechnology). After 48 h, hrCD14 (24 g/mL,
R&D Systems) was added to the apical well and transfer to the basal
well was measured via ELISA, as described above. RNA was  isolated
from Caco-2 monolayers and analyzed by real time PCR as described
above.
Immunocytochemistry and microscopy
Following transport assays, monolayers were washed twice
with PBS and ﬁxed with neutral buffered formalin. Fixed mono-
layers on Transwell membranes were excised from the plastic
trays, hydrated for 1 h with buffer (0.1% Tween, 0.15 M NaCl, 5 mM
EDTA 20 mM HEPES pH 7.5, 0.02% NaN3) and blocked with 1%
BSA in buffer for 30 min. Membranes were incubated overnight
with mouse anti-CD14 antibodies (1 g/mL, UCH-M1, Santa
Cruz Biotechnology) at 4◦C, washed three times with buffer, and
incubated with FITC-labeled goat anti-mouse IgG antibodies
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Fig. 1. Quantity of sCD14 in the stomach contents (milk clot, left panel) and blood (right panel) of mouse pups ingesting milk with or without sCD14. On day six post-partum,
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wups  were fostered to different mothers (dotted line). (A and B), wild type pups fost
,  CD14−/− pups fostered to wild type mothers; (G and H), CD14−/− pups fostered to
10 ng/mL, F0257, Sigma–Aldrich) for 1.5 h at room temperature.
eparate membranes were incubated similarly with rabbit anti-
LR4 antibodies (1 g/mL, SC-10741, Santa Cruz Biotechnology),
ollowed by three washes and incubation with FITC-labeled
oat anti-rabbit IgG antibody (10 ng/mL, F9887 Sigma–Aldrich).
embranes were washed three times with buffer and stained
ith Hoechst (10 g/mL, Sigma–Aldrich) for 1 h at 4 ◦C, followedo wild type mothers; (C and D), wild type pups fostered to CD14−/− mothers; E and
−/− mothers. *, P < 0.05 by t-test, n = 3.
by three more washes with buffer. Membranes were mounted
on slides using ProLong Gold Anti-fade Reagent (Life Technolo-
gies) with a coverslip. Microscopy was performed using an Axio
Observer D1 microscope (Carl Zeiss, Göttingen, Germany) and
images were prepared using Axio Vision 4.8.2 software (Carl Zeiss).
Relative signal intensities were determined using ImageJ (NIH,
Bethesda, MD,  USA).
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Fig. 2. Intactness of sCD14 in the stomach contents and blood of mouse pups ingest-
ing milk with or without sCD14. (A) Wild type pups fostered to wild type mothers.
(B) Wild type pups fostered to CD14−/− mothers; (C) CD14−/− pups fostered to wild
type mothers; (D) CD14−/− pups fostered to CD14−/− mothers. Dotted line indicates40 T.L. Ward et al. / Immun
tatistical analysis
Data were analyzed by 2-tailed paired or unpaired t-tests (Sigma
lot 12.1, Systat, San Jose, CA, USA). An alpha level of <0.05 was
onsidered signiﬁcant. In the cases where the measurands were
elow the level of detection (see ﬁgures, “Not detected”) values
ere assumed to be zero. For real time PCR data, a comparative Ct
ethod with GAPDH as endogenous control was used, with sta-
istical differences calculated between mean RQ-values for each
xperimental group.
esults
CD14 from milk is transferred to the blood of pups
In CD14−/− pups, CD14 was not detected in neither the stom-
ch contents nor blood prior to fostering the pups to different
others (Fig. 1E and F). Once fostered to WT  mothers, sCD14
as detected in the blood of CD14−/− pups at day eight PP (two
ays post-foster) at a concentration of 0.16 ± 0.09 g/mL, which
ecreased to non-detectable levels by day ten PP (4 days post-
oster, P < 0.001, Fig. 1F). This decrease in blood sCD14 coincided
ith a decrease in sCD14 concentrations in the milk of WT  mice,
hich signiﬁcantly decreased from 2.23 ± 0.37 g/mL at day seven
P to 0.02 ± 0.01 g/mL at day ten PP (P < 0.001, Fig. 1A). The
ndogenous level of circulating sCD14 observed in mouse pups
hanged over time. In WT  pups fostered to WT  mothers, sCD14
as observed at 0.69 ± 0.14 g/mL in the blood which signiﬁcantly
ecreased to 0.31 ± 0.04 g/mL by day nine PP (P = 0.011, Fig. 1B).
n WT pups fostered to CD14−/− mothers, sCD14 concentrations in
he blood were similar to that of WT  pups fostered to WT moth-
rs. At day six PP, sCD14 was detected at 0.63 ± 0.15 g/mL in
he blood of WT  pups (pre-foster, Fig. 1 D). The concentration of
CD14 in the blood decreased to 0.16 ± 0.01 g/mL on day seven
P when fostered to CD14−/− mothers (P = 0.006), and was  sim-
lar to the amount in WT  pups fostered to WT  mothers by day
ine PP (0.20 ± 0.10 g/mL P > 0.05). Soluble CD14 was  not detected
n CD14−/− pups fostered to CD14−/− mothers at any time point
Fig. 1H).
A portion of the sCD14 in the stomach contents and blood of
ups from all treatment groups was conﬁrmed to be intact (48 kDa,
ig. 2). The amount of intact sCD14 in the stomach contents and
lood of pups visualized by western blot also corresponded to the
CD14 concentrations obtained by ELISA (Fig. 1).
CD14 transferred to the blood remains functional
CD14−/− pups fostered to WT  mothers had signiﬁcantly higher
L-6 and TNF- expression following LPS-injection (3225 ± 610 and
5.9 ± 2.7 fold increase, respectively) in comparison to CD14−/−
ups fostered to CD14−/− mothers (693 ± 184 and 6.1 ± 1.5-fold
ncrease for IL-6 and TNF-, respectively, (P = 0.002, P = 0.005)
ig. 3). The levels of sCD14 did not increase post-LPS injection in
D14−/− pups irrespective of the foster mothers’ genotype (Fig. 3C).
T pups fostered to WT  mothers showed an increase in circulating
CD14 levels (1.6 ± 0.1-fold increase), IL-6 levels (5333 ± 853-fold
ncrease) and TNF- levels (40.3 ± 8.2) post-LPS injection (Fig. 3).
T pups fostered to CD14−/− mothers showed a signiﬁcantly
igher increase in IL-6 expression post-LPS injection (7764 ± 946-
old increase) in comparison to all other genotype/foster groups
P < 0.031, Fig. 3A). Conversely, sCD14 and TNF- levels post-LPS
njection in WT  pups fostered to CD14−/− mothers (2.0 ± 0.3-fold
ncrease and 41.7 ± 12.5-fold increase, respectively) were not sig-
iﬁcantly different from that of WT  pups fostered to WT  mothers
P > 0.05, Fig. 3).when the pups were fostered to different mothers.
sCD14 is transferred by human cells in vitro
When added to the apical media of Caco-2 cell Transwell assays,
hrCD14 was transcytosed through cell monolayers and into the
basal media (Fig. 4). The amount of hrCD14 transcytosed was
dependent on the initial dose in the apical well; higher initial con-
centrations resulted in signiﬁcantly more hrCD14 observed in the
basal well (P < 0.017, Fig. 4). After two  hours of incubation, up to
3.41 ± 0.06% of the initial hrCD14 added to the apical well was
transcytosed to the basal well (Fig. 4).
The integrity of the membrane was  monitored by passive dif-
fusion of Lucifer Yellow, which was minimally detected in the
basal media (Supplemental Fig. S2). The intactness of pre- and
post-transcytosed hrCD14 was  monitored by Western blot, which
showed hrCD14 from the apical and basal well to be intact (48 kDa,
Fig. 4).
Supplementary Fig. S2 related to this article can be found, in the
online version, at http://dx.doi.org/10.1016/j.imbio.2014.03.008.
To conﬁrm the cellular uptake of hrCD14 by Caco-2 monolayers,
hrCD14 was monitored by immunocytochemistry and microscopy.
The amount of hrCD14 within the Caco-2 cells was dependent on
the initial apical hrCD14 concentration (Fig. 5), further conﬁrming
the ELISA results shown in Fig. 4. The production of endogenous
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Fig. 3. Immune response to LPS following sCD14 ingestion in mouse pups, assessed via sCD14, TNF-alpha, and IL-6 levels. Pups were fostered to mothers expressing (WT)
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br  not expressing sCD14 (CD14−/−) in their milk and blood was sampled pre and p
easured by quantifying sCD14 (A), IL-6 (B) and TNF-alpha (C) by ELISA and is expre
y  t-test, n = 3.
D14 (mCD14 and sCD14) by Caco-2 cells was also observed by
icroscopy (Fig. 5A).
CD14 transfer by Caco-2 cells involves TLR4
TLR4 expression was observed in Caco-2 cells but not with
nother intestinal epithelial cell line, HT29, via real time PCR
P < 0.001, Fig. 6). Following TLR4-speciﬁc siRNA treatment, TLR4
xpression was signiﬁcantly decreased in Caco-2 cells in com-
arison to control siRNA (scrambled) or non-treated Caco-2 cells
P < 0.002, Fig. 7A). Knockdown of TLR4 expression resulted in a
igniﬁcant decrease in sCD14 transfer across Caco-2 monolayers.
peciﬁcally, in control Caco-2 cells, 3.45 ± 0.13% of hrCD14 was
ransferred to the basal media, whereas 0.005 ± 0.001% of hrCD14
as transferred from the apical to basal media in TLR-siRNA treated
ells (P < 0.001, Fig. 7B).
Additionally, the role of TLR4 in CD14 transfer was monitored
y microscopy (Fig. 8). Regardless of siRNA treatment, Caco-2S injection (200 ng/g body weight) on day two post-foster. Immune response was
s a fold increase over pups fostered similarly but injected with PBS alone. *, P < 0.05
cells were able to internalize hrCD14 upon exposure (no hrCD14
compared to hrCD14 exposure, P < 0.037, Fig. 8). Interestingly, the
amount of sCD14 internalized did not signiﬁcantly change despite
knockdown of TLR4 (P > 0.135, Fig. 4C). Therefore, knockdown of
TLR4 seems to impair transfer of CD14 across monolayers (Fig. 7),
but not uptake of CD14 (Fig. 8).
Discussion
sCD14 from milk is transferred to the blood of pups
Ingested sCD14 was transferred to the blood of mice as shown
by detection of CD14 in the blood of CD14−/− pups fostered to WT
mothers (0.16 ± 0.09 g/mL, day eight PP, Fig. 1F). Ingested sCD14
contributed approximately 26.7% of the circulating sCD14 on day
eight PP, as assessed by comparing the concentration of sCD14 in
the blood of WT pups fostered to WT mothers to CD14−/− pups
fostered to WT  mothers (0.60 ± 0.14 g/mL and 0.16 ± 0.09 g/mL,
542 T.L. Ward et al. / Immunobiology 219 (2014) 537–546
Fig. 4. Quantity (A) and intactness (B) of sCD14 transferred across human intestinal
monolayers in vitro. Caco-2 cells were grown and differentiated as monolayers in
Transwell assays. Human recombinant CD14 (hrCD14) was added to apical medium
and transfer of hrCD14 to basal medium was  measured by ELISA. Intactness of
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Fig. 5. Visualization of sCD14 within human intestinal cells treated with sCD14
in  vitro. Caco-2 cells were grown and differentiated as monolayers in Transwell
assays. Human recombinant CD14 (hrCD14) was  added to the apical medium and
presence of hrCD14 within the monolayers was  detected by microscopy (A) afterrCD14 in the apical (a) and basal (b) medium was detected by western blot. *,
 < 0.05 by t-test, n = 3.
espectively, Fig. 1). The contribution of ingested sCD14 to cir-
ulating levels of sCD14 pups was signiﬁcant earlier in lactation,
hen sCD14 levels in milk were higher (Fig. 1A). Speciﬁcally, when
omparing WT  pups fostered to CD14−/− mothers to WT  pups fos-
ered to WT  mothers, the amount of circulating sCD14 signiﬁcantly
ecreased from 0.60 ± 0.14 g/mL at day eight PP (WT  to WT)  to
.35 ± 0.05 g/mL at day eight PP (WT  to CD14−/−) due to the
bsence of sCD14 from their diet (P = 0.016, Fig. 1B and D). Over
ime, the amount of sCD14 in the mouse milk decreased to non-
etectable levels, but the level of circulating sCD14 in WT pups did
ot show a similar decrease (Fig. 1). For example, when comparing
CD14 levels in the blood of WT pups fostered to WT  mothers to WT
ups fostered to CD14−/− mothers, the amount of circulating sCD14
n days nine and ten PP do not signiﬁcantly differ between the
roups regardless of the absence of sCD14 from the diet of the WT
ups fostered to CD14−/− mothers (P > 0.05, Fig. 1B and D). The lack
f correlation between milk-sCD14 levels and circulating sCD14
evels after eight days of suckling suggests pups begin producing
ore of their own circulating sCD14 at this time and rely less on
ontributions from ingested sCD14.
A decrease in sCD14 levels during lactation is also seen in
umans, where sCD14 levels are reported as high as 26 g/mL
n colostrum, which decreases to 5 g/mL by 30 days PP (Collado
t al., 2012). Additionally, circulating sCD14 levels in infants do not
each levels similar to those in adults until four months PP (Jones
t al., 2002). Therefore, uptake of ingested sCD14 by infants as a
eans to compensate for a lack of endogenously produced sCD14
s likely a conserved mechanism in both rodents and humans. This
s supported by the observation of human intestinal cells transfer-
ing hrCD14 across monolayers in vitro (Fig. 4). When exposed to
rCD14, Caco-2 cells were able to internalize and transfer hrCD14
rom the apical to basal well of a Transwell assay in a dose-
ependent manner (Fig. 4).
Caco-2 monolayers have also been used as a model to
emonstrate the transcytosis of other milk components includ-
ng proteins, bacteria and viruses. For example -lactoglobulin, a2  h of incubation with or without hrCD14. Signal intensities for hrCD14 (B) were
calculated using ImageJ. *, P < 0.05 by t-test, n = 3.
major bovine milk allergen, was  recently shown to evade digestion
similarly to sCD14, and was  also transferred across Caco-2 mono-
layers in vitro (Picariello et al., 2013). Viruses found in human milk,
such as human T-cell leukemia virus type 1 (HTLV-1) which resides
within infected milk-lymphocytes in HTLV-1 positive mothers, has
also been shown to transfer across Caco-2 monolayers. This trans-
fer occurs via transcytosis despite the resistance of enterocytes to
HTLV-1 infection (Martin-Latil et al., 2012). Similarly, Caco-2 mono-
layers and brain microvascular endothelial cell monolayers have
been shown to transcytose Cronobacter, a type of bacteria linked to
neonatal meningitis (Giri et al., 2012). Cronobacter can be found in
human milk (Ward et al., 2013) and can also reside within pow-
dered infant formulas, the latter of which has been reported as a
source of neonatal meningitis outbreaks and discussed in a recent
review (Norberg et al., 2012).
In vivo uptake of other milk proteins, such as immunoglobulins,
has also been extensively studied. Recently, transcytosis of IgG by
intestinal cells of rats was imaged by electron tomography, which
showed the antibody to be taken up by epithelial cells along the
intestine and transported to the blood in an endosome dependent
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Fig. 6. TLR4 expression in Caco-2 and HT29 cells. Intestinal epithelial cell lines were
grown in monolayers and TLR4 expression was  determined by real time PCR (A).
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Fig. 7. Effect of TLR4 knockdown on sCD14 transfer by human intestinal cells in
vitro.  Caco-2 cells were grown and differentiated as monolayers in Transwell assays,
treated with TLR4 speciﬁc siRNA, scrambled siRNA or no siRNA, and TLR4 expressionLR4 (75 bp) and GAPDH (66 bp) amplicons were electrophoresed following PCR on
olyacrylamide gels (B).
athway (He et al., 2008; Ladinsky et al., 2012). Further analysis
evealed the intestinal cells of weaned animals had less multivesic-
lar bodies containing early endosomal markers in comparison to
eonatal animals (Ladinsky et al., 2012). The change in vesicle phe-
otype throughout suckling suggests the capacity of the neonatal
ntestine to transport functional proteins from the lumen of the
ntestine and into the blood diminishes during maturation. The
resent study observed sCD14 transport across a window of ﬁve
ays (days six through ten PP) and thus changes in sCD14 trans-
ort across the GI tract over time were likely not impacted greatly
y gut maturation (Fig. 1).
CD14 transferred to the blood remains functional
One clearly demonstrated function of CD14 (both mCD14 and
CD14) is its ability to recognize LPS from Gram-negative bacteria
nd initiate an innate immune response through TLR4 (Wright et al.,
990). Because of this, CD14−/− mice are resistant to LPS mediated
eptic shock, as minimal TNF- and IL-6 responses are observed
ollowing injection of LPS in concentrations normally lethal to WT
ice (Haziot et al., 1996). When CD14−/− pups were fostered to
T mothers, their level of circulating sCD14 increased as ingested
ilk-sCD14 was transferred to the blood (Fig. 1F). When injected
ith LPS, CD14−/− pups fostered to WT  mothers presented with
igniﬁcantly higher TNF- and IL-6 responses than CD14−/− pups
ostered CD14−/− mothers (P < 0.05, Fig. 3B and C). This suggests
hat ingested sCD14 transferred to the blood of pups retains its
bility to detect LPS.
CD14−/− pups fostered to WT  mothers had a signiﬁcantly lower
mmune response (both IL-6 and TNF-) following LPS injection in
omparison to WT  pups fostered to WT  mothers (P = 0.002, Fig. 3B
nd P = 0.007, Fig. 3C). This is likely due to the presence of only
CD14 and no mCD14 in the CD14−/− pups fostered to WT  moth-
rs. In WT mice, mCD14 can be found on monocytes, hepatocytes
nd intestinal epithelial cells where it is responsible for recogniz-
ng LPS and initiating the TLR4 mediated immune response (Guo
t al., 2013; Wang et al., 1998). Therefore, because mCD14 is foundwas  measured by real time PCR (A). Human recombinant CD14 (hrCD14) was added
to  apical media and transfer of hrCD14 to basal media was measured by ELISA (B).
*,  P < 0.05 by t-test, n = 4.
on numerous cells in WT  pups, WT  pups are more readily equipped
to recognize LPS regardless of sCD14 ingestion. When comparing
the immune response to LPS of WT  pups fostered to WT moth-
ers (WT  to WT)  to WT  pups fostered to CD14−/− mothers (WT  to
CD14−/−), there was a signiﬁcantly higher IL-6 response in WT  pups
fostered to CD14−/− mothers (P = 0.030, Fig. 3C). On the second day
post-foster, signiﬁcantly less sCD14 was observed in the blood of
WT pups fostered to CD14−/− mothers in comparison to WT pups
fostered to WT mothers (P = 0.016, Fig. 1B and D). As previously
stated, WT  pups express mCD14 on various cell types which are
then able to detect LPS, regardless of sCD14 ingestion. Although
milk sCD14 is capable of recognizing LPS and subsequently passing
LPS to TLR4 (Vidal et al., 2001), sCD14 can also sequester LPS away
from mCD14 expressing cells and bring LPS to the liver for clear-
ance by TLR4 expressing hepatocytes (Deng et al., 2013; Kitchens
et al., 2001). Therefore, the lower levels of sCD14 in WT  pups fos-
tered to CD14−/− mothers may  decrease the amount of LPS sent to
the liver for clearance, resulting in a higher immune response to
LPS exposure.sCD14 transfer by Caco-2 cells involves TLR4
Caco-2 cells in Transwell assays were able to transfer hrCD14
across the cell monolayer from the apical medium to the basal
544 T.L. Ward et al. / Immunobiology 219 (2014) 537–546
Fig. 8. Visualization of sCD14 and TLR4 within human intestinal cells treated with siRNA. Caco-2 cells were grown and differentiated as monolayers in Transwell assays and
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ere  detected by microscopy. Signal intensities for hrCD14 (D) were calculated usi
ith  hrCD14.*, P < 0.05 by t-test, n = 3.
edium in a dose dependent manner (Fig. 4). Previous research
as shown CD14 internalization to be independent of TLR4 (Zanoni
t al., 2011), however, given the role of CD14 in LPS recognition and
LR4 signaling, we hypothesized CD14 internalization by intestinal
ells may  involve TLR4. When TLR4 expression was  knocked down
sing siRNA, the capacity of Caco-2 cells to transport hrCD14 across
he monolayer was diminished (3.45 ± 0.13% of hrCD14 transferred
y control cells versus 0.005 ± 0.001% of hrCD14 transferred by
LR-siRNA treated cells, P < 0.001, Fig. 7B). Interestingly, although
he amount of hrCD14 transferred across the monolayers was  sig-
iﬁcantly less following TLR4 knockdown, the amount of hrCD14
nternalized (as measured by microscopy) did not signiﬁcantly
hange (P > 0.135, Fig. 8). Therefore, TLR4 may  be involved in the
ransfer of TLR4 to the basal side of cell monolayers as opposed
o apical uptake of CD14. The exact role of TLR4 in the transfer of
D14 across intestinal cells and whether TLR4 plays a role in sCD14
ransfer in vivo, however, remains unclear.
In rats, LPS transport across the intestinal epithelium ex vivo was
bserved to be inhibited using anti-CD14 or anti-TLR4 antibodies,
upporting a role of these two pattern recognition receptors in
ucosal LPS transport (Tomita et al., 2004). Similarly, a study using
ouse intestinal cells in vitro (m-ICc12) showed an increase of
D14 expression following LPS exposure, and LPS was internalized
nd colocalized with TLR4 within m-ICc12 cells (Hornef et al., 2002).
ecently, a study with Caco-2 cells showed that LPS increased TLR4
nd CD14 expression in intestinal monolayers, and a similar trenduman recombinant CD14 (hrCD14, left panels) and TLR4 expression (right panels)
ageJ. Black bars represent cells given no hrCD14, white bars represent cells treated
was observed in vivo along the mouse GI tract (Guo et al., 2013).
In healthy intestine, LPS does not permeate through the intestinal
barrier to a great extent (intestinal lumen to blood transfer), likely
due to a low presence of TLR4 and CD14 along the GI  tract (Guo
et al., 2013; Leaphart et al., 2007; Nanthakumar et al., 2011; Wolfs
et al., 2010). Once exposed to LPS, TLR4 and CD14 concentrations
increase, resulting in greater intestinal permeability (Guo et al.,
2013). It is likely that milk-derived sCD14 is able to cross the
intestinal barrier through involvement with LPS recognition, given
the demonstrated role of TLR4 in CD14 transfer in vitro (Fig. 7).
Implications of biologically active sCD14 post-ingestion
Although high concentrations of sCD14 in early-lactation milk
in conjunction with sCD14’s ability to transfer to the blood post-
ingestion suggest sCD14 is an important human milk protein,
sCD14’s role in infant health remains unknown. Similarly to follow-
ing LPS exposure as shown by Guo et al, TLR4 is also upregulated
along the GI tract of premature infants (Guo et al., 2013; Leaphart
et al., 2007; Nanthakumar et al., 2011; Wolfs et al., 2010). Once acti-
vated, TLR4 is able to induce a proinﬂammatory response, and this
activation in the intestine has been implicated as a cause of NEC
(Hackam et al., 2013; Neu and Walker, 2011 for review). Incidence
of NEC is higher in premature infants and lower birth weight infants
have the highest NEC-caused death rates of up to 30% (Fitzgibbons
et al., 2009). During NEC, activation of TLR4 leads to autophagy
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nd subsequent impaired migration of intestinal epithelial cells
rom the crypts of the intestine resulting in decreased barrier
ntegrity (Neal et al., 2013). Additionally, TLR4 activation within the
ndothelium has recently been shown to reduce mesenteric per-
usion resulting in intestinal ischemia and increased NEC severity
Yazji et al., 2013). Activation of TLR4 may  be dependent on CD14,
ince blocking CD14 through inactivating antibodies decreased the
everity of induced NEC by decreasing the TLR4 immune response
s measured by IL-6 and TNF- expression (Chan et al., 2009). WT
ups not ingesting sCD14 were seen to have an increase in IL-6
esponse to LPS compared to those ingesting sCD14 (Fig. 3), which
onﬁrms previous studies that show increased sCD14 levels prior
o or at the time of LPS exposure dampen the LPS-induced immune
esponse (Haziot et al., 1995; Lee et al., 2003). Therefore, high lev-
ls of sCD14, such as those in colostrum and early lactation milk
26 g/mL), may  be beneﬁcial to the infant prior to exposure of LPS
o help mitigate an exaggerated immune response.
onclusions
Ingestion of sCD14 within milk results in the transfer of intact
CD14 from the GI tract to the circulatory system of mouse
ups. Transfer of sCD14 across the intestinal barrier involves TLR4
n vitro and newly circulating sCD14 derived from ingested sources
emains functional in its ability to detect LPS in vivo. High quan-
ities of sCD14 in early lactation milk implicate sCD14 as a factor
nﬂuencing infant health, especially given the role of the LPS recog-
ition pathway, which includes CD14 and TLR4, in the development
f NEC.
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